BASF and Sumitomo Chemical explore in vitro system for chemical safety evaluation
Application of fully functional cultured cells as alternative to animal testing.
Sumitomo Chemical Co. and BASF have agreed to collaborate on research into a more sustainable, in vitro system for chemical safety evaluation.
Recent years have seen an increase in stringent regulations for registration of agricultural chemicals and pharmaceuticals, and the demand to increase human relevance of safety studies. For these reasons, Sumitomo Chemical and BASF aim to create a system that supports the development of safe chemicals, while reducing the need for conventional animal testing.
As the first step in their research, Sumitomo Chemical and BASF aim to establish a new line of fully functional cultured cells to enable the safety evaluation of chemicals in a more efficient and more precise way than conventional methods.
Dr Peter Eckes, President of BASF Bioscience Research, said: “BASF celebrates its 150th anniversary this year, and we have a history of continuous commitment to sustainability throughout our operations. In this collaboration we are combining the strength of both companies to develop new methods to reduce animal testing.”
Ikuzo Ogawa, Managing Executive Officer of Sumitomo Chemical in charge of technology and research and development, said: “We will contribute to building a sustainable society through supplying safer chemicals. We are very delighted to work on the collaborative research of such great social significance in the year marking the 100th anniversary of the start of Sumitomo Chemical’s operations.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance